Epinoma
Overview
UNLOcKING THE NEXT FRONTIER OF BIOLOGY. We unlock deep insights into the epigenome with EpiAmp, the first methyl-preserving amplification technology.
Funding and backers
Team
11-50
employees, estimated range
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2021
Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Leverage an AI-powered consumer intelligence platform with i-Genie.ai. Unlock deep insights, predict behavior, and make smarter…

Early intervention. The next frontier in Alzheimer's disease.

The next frontier of specialty care.. Resolyst is the intelligence layer for AI-enabled specialty care. It extends the reach of the world's…

Crafting the next frontier of hand-drawn animation Kamikai, formerly iKHOR Labs, is the company behind WonderCanvas and MagicPen. We're a…

Soilytix was founded by people with a deep passion for soil biology. We believe the life beneath our feet deserves to be seen, understood…

Transforming biology from empirical to. Frontier AI lab training the first scientific poly-intelligence to read all the layers of biology…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

Y CombinatorVia a fund
6311 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff





